Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc., 34651 [2020-12180]

Download as PDF 34651 Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices (iv) indicate whether complainant, complainant’s licensees, and/or third party suppliers have the capacity to replace the volume of articles potentially subject to the requested exclusion order and/or a cease and desist order within a commercially reasonable time; and (v) explain how the requested remedial orders would impact United States consumers. Written submissions on the public interest must be filed no later than by close of business, eight calendar days after the date of publication of this notice in the Federal Register. There will be further opportunities for comment on the public interest after the issuance of any final initial determination in this investigation. Any written submissions on other issues must also be filed by no later than the close of business, eight calendar days after publication of this notice in the Federal Register. Complainant may file replies to any written submissions no later than three calendar days after the date on which any initial submissions were due. Any submissions and replies filed in response to this Notice are limited to five (5) pages in length, inclusive of attachments. Persons filing written submissions must file the original document electronically on or before the deadlines stated above and submit 8 true paper copies to the Office of the Secretary by noon the next day pursuant to § 210.4(f) of the Commission’s Rules of Practice and Procedure (19 CFR 210.4(f)). Submissions should refer to the docket number (‘‘Docket No. 3457’’) in a prominent place on the cover page and/ or the first page. (See Handbook for Electronic Filing Procedures, Electronic Filing Procedures 1). Persons with questions regarding filing should contact the Secretary (202–205–2000). Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this Investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel,2 solely for cybersecurity purposes. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS.3 This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and of §§ 201.10 and 210.8(c) of the Commission’s Rules of Practice and Procedure (19 CFR 201.10, 210.8(c)). SUPPLEMENTARY INFORMATION: By order of the Commission. Issued: June 1, 2020. Lisa Barton, Secretary to the Commission. Drug Enforcement Administration Controlled substance JWH–018 (also known as AM678) 7118 I N 1-Pentyl3-(1-naphthoyl)indole. lotter on DSK9F5VC42PROD with NOTICES 18:21 Jun 04, 2020 Jkt 250001 BILLING CODE 7020–02–P [FR Doc. 2020–12180 Filed 6–4–20; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC ACTION: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–659] Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc. Notice of application. Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 4, 2020. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: Notice of application. Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 4, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: In accordance with 21 CFR 1301.33(a), this is notice that on May 7, 2020, Chemtos, LLC, 16713 Picadilly Court, Round Rock, Texas 78664–8544, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: SUPPLEMENTARY INFORMATION: Drug code 2 All contract personnel will sign appropriate nondisclosure agreements. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 I William T. McDermott, Assistant Administrator. 3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. VerDate Sep<11>2014 7118 Schedule The company plans to manufacture small quantities of the listed controlled substance to make reference standards for distribution to its customers. Controlled substance 1 Handbook for Electronic Filing Procedures: https://www.usitc.gov/documents/handbook_on_ filing_procedures.pdf. Drug code [Docket No. DEA–655] [FR Doc. 2020–12151 Filed 6–4–20; 8:45 am] ACTION: In accordance with 21 CFR 1301.33(a), this is notice that on May 4, 2020, Sigma Aldrich Research Biochemicals, Inc., 400–600 Summit Drive, Burlington, Massachusetts 01803, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance: 1233 1235 1237 Schedule I I I 3 Electronic Document Information System (EDIS): https://edis.usitc.gov. E:\FR\FM\05JNN1.SGM 05JNN1

Agencies

[Federal Register Volume 85, Number 109 (Friday, June 5, 2020)]
[Notices]
[Page 34651]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12180]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-659]


Bulk Manufacturer of Controlled Substances Application: Sigma 
Aldrich Research Biochemicals, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before August 4, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on May 4, 2020, Sigma Aldrich Research Biochemicals, 
Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803, applied to 
be registered as a bulk manufacturer of the following basic class(es) 
of controlled substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
JWH-018 (also known as AM678) 7118 I N      7118  I
 1-Pentyl-3-(1-naphthoyl)indole.
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substance to make reference standards for distribution to 
its customers.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-12180 Filed 6-4-20; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.